APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.

dc.contributor.author

Bruggeman, Leslie A

dc.contributor.author

Wu, Zhenzhen

dc.contributor.author

Luo, Liping

dc.contributor.author

Madhavan, Sethu

dc.contributor.author

Drawz, Paul E

dc.contributor.author

Thomas, David B

dc.contributor.author

Barisoni, Laura

dc.contributor.author

O'Toole, John F

dc.contributor.author

Sedor, John R

dc.date.accessioned

2021-02-01T18:46:07Z

dc.date.available

2021-02-01T18:46:07Z

dc.date.issued

2019-01

dc.date.updated

2021-02-01T18:46:05Z

dc.description.abstract

African polymorphisms in the gene for Apolipoprotein L1 (APOL1) confer a survival advantage against lethal trypanosomiasis but also an increased risk for several chronic kidney diseases (CKD) including HIV-associated nephropathy (HIVAN). APOL1 is expressed in renal cells, however, the pathogenic events that lead to renal cell damage and kidney disease are not fully understood. The podocyte function of APOL1-G0 versus APOL1-G2 in the setting of a known disease stressor was assessed using transgenic mouse models. Transgene expression, survival, renal pathology and function, and podocyte density were assessed in an intercross of a mouse model of HIVAN (Tg26) with two mouse models that express either APOL1-G0 or APOL1-G2 in podocytes. Mice that expressed HIV genes developed heavy proteinuria and glomerulosclerosis, and had significant losses in podocyte numbers and reductions in podocyte densities. Mice that co-expressed APOL1-G0 and HIV had preserved podocyte numbers and densities, with fewer morphologic manifestations typical of HIVAN pathology. Podocyte losses and pathology in mice co-expressing APOL1-G2 and HIV were not significantly different from mice expressing only HIV. Podocyte hypertrophy, a known compensatory event to stress, was increased in the mice co-expressing HIV and APOL1-G0, but absent in the mice co-expressing HIV and APOL1-G2. Mortality and renal function tests were not significantly different between groups. APOL1-G0 expressed in podocytes may have a protective function against podocyte loss or injury when exposed to an environmental stressor. This was absent with APOL1-G2 expression, suggesting APOL1-G2 may have lost this protective function.

dc.identifier

PONE-D-19-19316

dc.identifier.issn

1932-6203

dc.identifier.issn

1932-6203

dc.identifier.uri

https://hdl.handle.net/10161/22302

dc.language

eng

dc.publisher

Public Library of Science (PLoS)

dc.relation.ispartof

PloS one

dc.relation.isversionof

10.1371/journal.pone.0224408

dc.subject

Kidney Glomerulus

dc.subject

Animals

dc.subject

Mice, Inbred BALB C

dc.subject

Mice, Transgenic

dc.subject

Humans

dc.subject

Mice

dc.subject

AIDS-Associated Nephropathy

dc.subject

Disease Models, Animal

dc.subject

Genetic Predisposition to Disease

dc.subject

Apolipoproteins

dc.subject

Polymorphism, Genetic

dc.subject

Podocytes

dc.subject

Renal Insufficiency, Chronic

dc.subject

Genetic Variation

dc.subject

Transcriptome

dc.subject

Apolipoprotein L1

dc.title

APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.

dc.type

Journal article

pubs.begin-page

e0224408

pubs.issue

10

pubs.organisational-group

School of Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Medicine, Nephrology

pubs.organisational-group

Duke

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.publication-status

Published

pubs.volume

14

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.pdf
Size:
1012.43 KB
Format:
Adobe Portable Document Format